{
  "id": 2393019,
  "title": "CEPI commits $4.17m to study vaccine protection against Ebola virus",
  "url": "https://urgent.news/2026/08/21/cepi-commits-4-17m-to-study-vaccine-protection-against-ebola-virus",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-21T14:42:37.000Z",
  "source": {
    "name": "Premium Times",
    "slug": "premium-times",
    "url": "https://www.premiumtimesng.com/health/health-news/904492-cepi-commits-4-17m-to-study-vaccine-protection-against-ebola-virus.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "The research comes as the Democratic Republic of the Congo (DRC) continues to battle the outbreak caused by Bundibugyo ebolavirus. The post CEPI commits $4.17m to study vaccine protection against Ebola virus appeared first on Premium Times Nigeria .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "Scientists deploy Merck’s Ebola vaccine in DRC",
        "url": "https://urgent.news/2026/08/21/scientists-deploy-mercks-ebola-vaccine-in-drc",
        "published": "2026-08-21T13:04:41.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}